Cingulate submits FDA application for ADHD drug CTx-1301
Go back to Cingulate submits FDA application for ADHD drug CTx-1301| (NASDAQ: CING) | Delayed: 4.95 -0.14 (2.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.09 | 52 Week High | $ | |||
| Open | $5.09 | 52 Week Low | $ | |||
| Day High | $5.17 | P/E | N/A | |||
| Day Low | $4.93 | EPS | $ | |||
| Volume | 69,358 | |||||
| (NASDAQ: CINGW) | Delayed: 0.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.03 | 52 Week High | $ | |||
| Open | $0.03 | 52 Week Low | $ | |||
| Day High | $0.03 | P/E | N/A | |||
| Day Low | $0.03 | EPS | $ | |||
| Volume | 100 | |||||
